for indolent and mantle cell lymphomas
MD, FRCPC, Chief, Division of Hematology &
Hematologic Malignancies, University of Calgary;
Provincial Leader, Hematology Tumor Team,
AHS Cancer Care.
To view the complete article click
here (pdf format)
: Improved PFS with bendamustine +